Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Obesity 2 Polycystic Ovary Syndrome 1 Overweight 1 Breast Neoplasms 1

Interventions

Metformin 2 sultamicillin 1 semaglutide 1 Ursodeoxycholic Acid 1 Tirzepatide 1 Resistance Training 1 Propofol 1 Progestins 1 Nutrition Assessment 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Magnetic Resonance Spectroscopy 1 Hysteroscopy 1 Exercise 1 Exenatide 1 Estrogen Replacement Therapy 1 Docosahexaenoic Acids 1 Cyproterone 1 (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Overweight × Tirzepatide × Clear all

NCT07326111 2026-01-08

PERIODS

University of Bonn

Phase 4 Recruiting

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡